Correlation Between Crispr Therapeutics and Vertex Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Crispr Therapeutics and Vertex Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Crispr Therapeutics and Vertex Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Crispr Therapeutics AG and Vertex Pharmaceuticals, you can compare the effects of market volatilities on Crispr Therapeutics and Vertex Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Crispr Therapeutics with a short position of Vertex Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Crispr Therapeutics and Vertex Pharmaceuticals.
Diversification Opportunities for Crispr Therapeutics and Vertex Pharmaceuticals
0.85 | Correlation Coefficient |
Very poor diversification
The 3 months correlation between Crispr and Vertex is 0.85. Overlapping area represents the amount of risk that can be diversified away by holding Crispr Therapeutics AG and Vertex Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Vertex Pharmaceuticals and Crispr Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Crispr Therapeutics AG are associated (or correlated) with Vertex Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Vertex Pharmaceuticals has no effect on the direction of Crispr Therapeutics i.e., Crispr Therapeutics and Vertex Pharmaceuticals go up and down completely randomly.
Pair Corralation between Crispr Therapeutics and Vertex Pharmaceuticals
Given the investment horizon of 90 days Crispr Therapeutics is expected to generate 2.28 times less return on investment than Vertex Pharmaceuticals. In addition to that, Crispr Therapeutics is 2.26 times more volatile than Vertex Pharmaceuticals. It trades about 0.01 of its total potential returns per unit of risk. Vertex Pharmaceuticals is currently generating about 0.06 per unit of volatility. If you would invest 29,346 in Vertex Pharmaceuticals on November 1, 2024 and sell it today you would earn a total of 14,494 from holding Vertex Pharmaceuticals or generate 49.39% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Strong |
| Accuracy | 100.0% |
| Values | Daily Returns |
Crispr Therapeutics AG vs. Vertex Pharmaceuticals
Performance |
| Timeline |
| Crispr Therapeutics |
| Vertex Pharmaceuticals |
Crispr Therapeutics and Vertex Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Crispr Therapeutics and Vertex Pharmaceuticals
The main advantage of trading using opposite Crispr Therapeutics and Vertex Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Crispr Therapeutics position performs unexpectedly, Vertex Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Vertex Pharmaceuticals will offset losses from the drop in Vertex Pharmaceuticals' long position.| Crispr Therapeutics vs. Beam Therapeutics | Crispr Therapeutics vs. Editas Medicine | Crispr Therapeutics vs. Caribou Biosciences | Crispr Therapeutics vs. Verve Therapeutics |
| Vertex Pharmaceuticals vs. Biomarin Pharmaceutical | Vertex Pharmaceuticals vs. Sarepta Therapeutics | Vertex Pharmaceuticals vs. Alnylam Pharmaceuticals | Vertex Pharmaceuticals vs. Intellia Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Balance Of Power module to check stock momentum by analyzing Balance Of Power indicator and other technical ratios.
Other Complementary Tools
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Stocks Directory Find actively traded stocks across global markets | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity |